TT
TG Therapeutics Inc
🇺🇸XNAS.TGTXUnited StatesHealthcare
$53.41USDdown -0.59 (-1.09%)OpenEnd of day3:33 PM
Price$53.41-0.59 (-1.09%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US88322Q1085
- CUSIP
- 048785109
Company
- Employees
- 399
- Headquarters
- Morrisville, United States
- CEO
- Mr. Michael S. Weiss Esq., J.D.
Market
- Shares outstanding
- 153.1M
- Market cap
- $8.18B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $8.18B
- EPS LTM
- $2.81
- P/E LTM
- 19.57
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $799.54M+76.08%up year on year
- Net income
- $441.49M+630.24%up year on year
- Gross margin
- 82.36%-5.28%down year on year
- Free cash flow
- -$560K+99.05%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.